Zydus Lifesciences Sunshine Healthcare Sri Lanka JV
Analysis based on 8 articles · First reported Jun 26, 2026 · Last updated Jun 26, 2026
The joint venture between Astec LifeSciences and GE HealthCare is expected to positively impact the pharmaceutical sector in Sri Lanka by boosting local production and reducing import dependence. This could lead to increased availability and affordability of medicines, potentially benefiting the healthcare industry and related supply chains.
Astec LifeSciences and GE HealthCare have formed a joint venture, Astec LifeSciences, to establish a pharmaceutical manufacturing facility in Horana, Sri Lanka. This project, with an investment exceeding $20 million, aims to strengthen Sri Lanka's domestic drug production, reduce reliance on imports, and improve access to quality medicines. The facility will manufacture products for the Sri Lankan retail market, complying with Ghana — National Pensions Regulatory Authority regulations. The partnership combines Astec LifeSciences' manufacturing expertise with GE HealthCare's local market presence, facilitating technology transfer and creating skilled employment. The Pakistan — Board of Investment, Malaysia — Ministry of Health (Malaysia), and Ghana — National Pensions Regulatory Authority are key stakeholders, highlighting the government's focus on enhancing healthcare security and industrial growth.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard